Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No other content appears to be affected.
    Difference
    0.0%
    Check dated 2026-04-16T10:47:58.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Sponsor attribution updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company, replacing Karuna Therapeutics.
    Difference
    0.1%
    Check dated 2026-04-02T00:33:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer revision badge updated from Revision: v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:59:28.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Local Institution - 315 and related topics (Schizophrenia; MedlinePlus Genetics). Removed contact details for UMHAT 'Dr Georgi Stranski' and Maya Stoimenova-Popova at Site 315.
    Difference
    0.3%
    Check dated 2026-03-18T14:52:00.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    - Added Revision: v3.4.3 and removed references to Schizophrenia, related topics (MedlinePlus Genetics), and Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:40:32.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added updated contact phone number (314-498-9799) and collaborator information (Karuna Therapeutics, Inc., a Bristol Myers Squibb company).
    Difference
    0.1%
    Check dated 2026-02-25T07:53:33.000Z thumbnail image

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.